Latest psilocybin News

Why, for some, psychotherapy might be a better treatment for depression than drugs
How psilocybin potentially works to reverse the cognitive rigidity that is the hallmark of anorexia
Two charged, over $130K cash and large commercial quantity drugs seized
Psilocybin ‘Magic Mushroom’ Operation Charges in Marsden, QLD
Psychedelics could make mental health worse in people with a personality disorder
Psilocybin Clinical Trial Sponsored by Clairvoyant Therapeutics Reaches 90% Randomization
New trial to investiagte benefits of psilocybin in hard-to-treat patients
Optimi Health Congratulates Lykos Therapeutics on FDA Priority Review of New Drug Application And Releases MDMA Production Video
Psilocybin has treatment potential for a range of psychiatric conditions but remains poorly understood
Clairvoyant Surpasses 50 Per Cent Randomization in its Phase 2b Psilocybin Therapy Trial for Alcohol Use Disorder
How can you define a ‘drug’? Nobody really knows
Emyria secures ethics endorsement for MDMA authorised prescriber application
Drug lab located at Tarragindi, QLD
QIMR Berghofer trials psychedelic-assisted treatment for prolonged grief
Vaping products, medicinal cannabis and the wellness industry included in 2023-24 compliance and enforcement priorities
Monash expert: New Nature Medicine study into the use of psychedelic substance, psilocybin, for the treatment of anorexia nervosa
Police operation concludes at Splendour in Grass 2023
Ketamine injections for depression? A new study shows promise, but it’s one of many options
Do psychedelics really work to treat depression and PTSD? Here’s what the evidence says
Update on MDMA and psilocybin access and safeguards from 1 July 2023
Psychedelic-assisted therapy clinic GoodMind Therapeutics launches in Australia to offer hope for depression and PTSD sufferers
Psychedelic therapies for some mental illnesses will soon be legal – but experts still have questions
Police charge man with drug offences – Surry Hills
Emyria to expand MDMA programs following TGA psychedelic decision ‘
Monash Expert: TGA change to classification of psilocybin and MDMA
Change to classification of psilocybin and MDMA to enable prescribing by authorised psychiatrists
Baylor launches program focused on bioethics and health policy of psychedelics research
Australias biggest research trial using psychedelics to treat depression to commence in 2023
Almost 100 charged with drug offences, NSW
Another charged as part of drug trafficking investigation
Further three charged as part of drug trafficking investigation